Skip to main content
. 2022 Oct 17;12(10):1727. doi: 10.3390/jpm12101727

Table 4.

Metabolites and their pathways which are different between autism spectrum disorder with neurodevelopmental regression and control participants.

Significant Metabolites Significant Pathways
Metabolite Fold ∆ Pathway Matched Metabolites Impact
Cytidine *** 9.66 Aminoacyl-tRNA biosynthesis *** L-Asparagine *, L-Histidine *,
Glycine **, L-Serine **
0.17
Taurine *** 7.54
Adenosine triphosphate *** 6.86 Histidine metabolism ** L-Histidine*, 1-Methylhistamine * 0.31
Glycine ** 6.49 Glyoxylate and dicarboxylate metabolism * L-Serine **, Glycine ** 0.15
Dodecanoic acid ** 0.20 Glycine, serine and threonine metabolism * L-Serine **, Glycine ** 0.46
D,L-Acetyl-carnitine ** 4.84
Dihydroxyacetone ** 4.76
Acetamide ** 4.69
L-Histidine ** 4.60
Hydroxykynurenine ** 4.54
L-Serine ** 4.49
1-Methylhistamine * 4.16
L-Asparagine * 3.94
trans-Aconitic acid * 0.28
2,3,4,5-Tetrahydroxypentanoic acid * 3.49
Capric acid * 0.30
Heptadecanoic acid * 3.33
2-Aminoisobutyric acid * 3.31
Isobutyric acid * 3.27

* p ≤ 0.05, ** p ≤ 0.01; *** p ≤ 0.001.